Regtechtimes on MSN4d
Japanese Astellas Employee Faces Prolonged Detention in China Without ExplanationA Japanese man working for Astellas Pharma Inc. in China was taken into custody by Chinese authorities, and it has now been ...
Former CDP Secretary-General Katsuya Okada has called for stepping up interaction between 'high-level' Japanese and Chinese ...
Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer. The Japanese pharma said its wholly-owned subsidiary Universal ...
Four Japanese drugmakers – Astellas, Eisai, Daiichi Sankyo, and Takeda – have joined forces in a partnership intended to reduce the environmental impact of pharmaceutical packaging. The ...
A Japanese man, who was detained by Chinese authorities, will likely continue to remain in detention despite the Japanese ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Japan became the first country to qualify for the 2026 men’s World Cup after it beat Bahrain 2-0 at Saitama Stadium on Thursday. Second-half goals from Daichi Kamada and Takefusa Kubo were ...
Japan pharmaceutical manufacturing market was valued at US$ 34.7 billion in 2024 and is projected to reach a market size of US$ 62.0 billion by 2033 at a CAGR of 6.64% during the forecast period ...
1d
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback